Glenmark receives ANDA approval for Fluocinolone Acetonide Oil, 0.01% (Ear Drops)
Capital MarketGlenmark Pharmaceuticals Inc. USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fluocinolone Acetonide Oil, 0.01% (Ear Drops), a generic version of DermOtic1 Oil, 0.01% (Ear Drops), of Hill Dermaceuticals, Inc.
According to IQVIA sales data for the 12 month period ending October 2018, the DermaOtic Oil, 0.01% (Ear Drops) market2 achieved annual sales of approximately $18.1 million.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
